FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2535162854> ?p ?o ?g. }

• W2535162854 endingPage "79571" @default.
• W2535162854 startingPage "79557" @default.
• W2535162854 abstract "TRAF6 (TNF Receptor-Associated Factor 6) is an E3 ubiquitin ligase that contains a Ring domain, induces K63-linked polyubiquitination, and plays a critical role in signaling transduction. Our previous results demonstrated that TRAF6 is overexpressed in melanoma and that TRAF6 knockdown dramatically attenuates tumor cell growth and metastasis. In this study, we found that EGCG can directly bind to TRAF6, and a computational model of the interaction between EGCG and TRAF6 revealed that EGCG probably interacts with TRAF6 at the residues of Gln54, Gly55, Asp57 ILe72, Cys73 and Lys96. Among these amino acids, mutation of Gln54, Asp57, ILe72 in TRAF6 could destroy EGCG bound to TRAF6, furthermore, our results demonstrated that EGCG significantly attenuates interaction between TRAF6 and UBC13(E2) and suppresses TRAF6 E3 ubiquitin ligase activity in vivo and in vitro. Additionally, the phosphorylation of IκBα, p-TAK1 expression are decreased and the nuclear translocation of p65 and p50 is blocked by treatment with EGCG, leading to inactivation of the NF-κB pathway. Moreover, EGCG significantly inhibits cell growth as well as the migration and invasion of melanoma cells. Taken together, these findings show that EGCG is a novel E3 ubiquitin ligase inhibitor that could be used to target TRAF6 for chemotherapy or the prevention of melanoma." @default.
• W2535162854 created "2016-10-28" @default.
• W2535162854 creator A5023743448 @default.
• W2535162854 creator A5033081847 @default.
• W2535162854 creator A5036994170 @default.
• W2535162854 creator A5038302775 @default.
• W2535162854 creator A5040219665 @default.
• W2535162854 creator A5052226982 @default.
• W2535162854 creator A5073568638 @default.
• W2535162854 creator A5080134626 @default.
• W2535162854 creator A5085081570 @default.
• W2535162854 creator A5087173268 @default.
• W2535162854 date "2016-10-24" @default.
• W2535162854 modified "2023-10-16" @default.
• W2535162854 title "Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity" @default.
• W2535162854 cites W1521703963 @default.
• W2535162854 cites W1563224172 @default.
• W2535162854 cites W1580870868 @default.
• W2535162854 cites W1619248007 @default.
• W2535162854 cites W1968643486 @default.
• W2535162854 cites W1970351511 @default.
• W2535162854 cites W1977476580 @default.
• W2535162854 cites W1985588649 @default.
• W2535162854 cites W1988651464 @default.
• W2535162854 cites W1993736390 @default.
• W2535162854 cites W1995117011 @default.
• W2535162854 cites W1996917928 @default.
• W2535162854 cites W2000521531 @default.
• W2535162854 cites W2003824625 @default.
• W2535162854 cites W2003825045 @default.
• W2535162854 cites W2007251599 @default.
• W2535162854 cites W2008490492 @default.
• W2535162854 cites W2013826094 @default.
• W2535162854 cites W2015668903 @default.
• W2535162854 cites W2019399071 @default.
• W2535162854 cites W2022401041 @default.
• W2535162854 cites W2026495245 @default.
• W2535162854 cites W2032912275 @default.
• W2535162854 cites W2044877094 @default.
• W2535162854 cites W2046414971 @default.
• W2535162854 cites W2048128157 @default.
• W2535162854 cites W2051101560 @default.
• W2535162854 cites W2054764151 @default.
• W2535162854 cites W2059607531 @default.
• W2535162854 cites W2060020051 @default.
• W2535162854 cites W2067266295 @default.
• W2535162854 cites W2067401961 @default.
• W2535162854 cites W2071208972 @default.
• W2535162854 cites W2074517544 @default.
• W2535162854 cites W2075245880 @default.
• W2535162854 cites W2075758366 @default.
• W2535162854 cites W2079660414 @default.
• W2535162854 cites W2080148830 @default.
• W2535162854 cites W2081203532 @default.
• W2535162854 cites W2083498707 @default.
• W2535162854 cites W2084372424 @default.
• W2535162854 cites W2092057906 @default.
• W2535162854 cites W2099155924 @default.
• W2535162854 cites W2099548080 @default.
• W2535162854 cites W2102377211 @default.
• W2535162854 cites W2104743116 @default.
• W2535162854 cites W2110265610 @default.
• W2535162854 cites W2116063836 @default.
• W2535162854 cites W2123242499 @default.
• W2535162854 cites W2124748470 @default.
• W2535162854 cites W2125089329 @default.
• W2535162854 cites W2125552828 @default.
• W2535162854 cites W2125743475 @default.
• W2535162854 cites W2134660396 @default.
• W2535162854 cites W2138562391 @default.
• W2535162854 cites W2141620981 @default.
• W2535162854 cites W2142218576 @default.
• W2535162854 cites W2143428408 @default.
• W2535162854 cites W2143859123 @default.
• W2535162854 cites W2144770839 @default.
• W2535162854 cites W2145571705 @default.
• W2535162854 cites W2147005308 @default.
• W2535162854 cites W2153642560 @default.
• W2535162854 cites W2161828378 @default.
• W2535162854 cites W2168780527 @default.
• W2535162854 cites W2171239378 @default.
• W2535162854 cites W2171672609 @default.
• W2535162854 cites W2220812108 @default.
• W2535162854 cites W2255880084 @default.
• W2535162854 cites W2277264694 @default.
• W2535162854 cites W2284964826 @default.
• W2535162854 cites W315878885 @default.
• W2535162854 cites W4252545078 @default.
• W2535162854 cites W4376542711 @default.
• W2535162854 doi "https://doi.org/10.18632/oncotarget.12836" @default.
• W2535162854 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5346735" @default.
• W2535162854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27791197" @default.
• W2535162854 hasPublicationYear "2016" @default.
• W2535162854 type Work @default.
• W2535162854 sameAs 2535162854 @default.
• W2535162854 citedByCount "58" @default.
• W2535162854 countsByYear W25351628542017 @default.
• W2535162854 countsByYear W25351628542018 @default.

• next